Future Optimal Research and Care Evaluation - Aortic Stenosis

Recruiting now

Conditions studied: Severe Aortic Valve Stenosis, Moderate Aortic Valve Stenosis

In brief

In the past decade the treatment of aortic valve stenosis has rapidly changed. At first, transcatheter aortic valve implantation (TAVI) was a last resort option for inoperable patients. Nowadays, it more and more becomes an alternative to surgical aortic valve replacement (SAVR) - also in younger and lower risk patients. This poses important questions to clinical practise regarding the optimal life-time management of each individual patient. Which involves (durability of) treatment modality (surgical vs. transcatheter vs. conservative treatment) as well as the duration and type of the required antithrombotic treatment. Objective: to evaluate the effect of treatment modality (surgical vs. transcatheter vs. conservative treatment) and its complications on quality of life and survival in AoS patients.

Key facts

Study ID

NCT06168123

Run by

St. Antonius Hospital

People needed

800

Starts

2023-11-27

Expected to finish

2027-08-01

Last updated by the study team

2024-12-03

Who can join

Age: 18 and older, up to 110. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Older than 18 years of age
• Severe or moderate aortic stenosis
• No exclusion criteria are applicable to this registry

Where it is running

• St. Antonius Hospital — Nieuwegein, Netherlands (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.